Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07737795 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to evaluate whether treatment with the investigational drug OK-1 in combination with paclitaxel can reduce tumor burden in patients with advanced or recurrent endometrial cancer (A/R-EC).
Trial Details
NCT Number NCT07737795
Lead Sponsor University of Oklahoma
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Endometrial Cancer
Related terms Endometrial Neoplasms
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov